Subacute sclerosing panencephalitis and Salk vaccine.
D000293:Adolescent; D000328:Adult; D000956:Antigens, Viral / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D004340:Drug Contamination; D006801:Humans; D007223:Infant; D008457:Measles / Q000276:immunology; D008459:Measles virus / Q000276:immunology; D009520:New Zealand; D011054:Poliovirus Vaccine, Inactivated / Q000009:adverse effects*; D012423:Rural Health; D012572:School Health Services; D013539:Simian virus 40 / Q000276:immunology; D013344:Subacute Sclerosing Panencephalitis / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology / Q000382:microbiology
D000956:Antigens, Viral; D011054:Poliovirus Vaccine, Inactivated